node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
APBA1 | APBB2 | ENSP00000265381 | ENSP00000427211 | amyloid beta (A4) precursor protein-binding, family A, member 1 | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | 0.689 |
APBA1 | APLP2 | ENSP00000265381 | ENSP00000263574 | amyloid beta (A4) precursor protein-binding, family A, member 1 | amyloid beta (A4) precursor-like protein 2; May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5’-GTCACATG-3’(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts (By similarity) | 0.875 |
APBA1 | APP | ENSP00000265381 | ENSP00000284981 | amyloid beta (A4) precursor protein-binding, family A, member 1 | amyloid beta (A4) precursor protein | 0.933 |
APBA1 | C16orf70 | ENSP00000265381 | ENSP00000219139 | amyloid beta (A4) precursor protein-binding, family A, member 1 | chromosome 16 open reading frame 70 | 0.798 |
APBA1 | CASK | ENSP00000265381 | ENSP00000367408 | amyloid beta (A4) precursor protein-binding, family A, member 1 | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.964 |
APBA1 | CASKIN1 | ENSP00000265381 | ENSP00000345436 | amyloid beta (A4) precursor protein-binding, family A, member 1 | CASK interacting protein 1; May link the scaffolding protein CASK to downstream intracellular effectors (By similarity) | 0.709 |
APBA1 | FAM189A2 | ENSP00000265381 | ENSP00000257515 | amyloid beta (A4) precursor protein-binding, family A, member 1 | family with sequence similarity 189, member A2 | 0.680 |
APBA1 | KIF17 | ENSP00000265381 | ENSP00000247986 | amyloid beta (A4) precursor protein-binding, family A, member 1 | kinesin family member 17; Transports vesicles containing N-methyl-D-aspartate (NMDA) receptor 2B along microtubules (By similarity) | 0.683 |
APBA1 | MPP1 | ENSP00000265381 | ENSP00000358547 | amyloid beta (A4) precursor protein-binding, family A, member 1 | membrane protein, palmitoylated 1, 55kDa; Essential regulator of neutrophil polarity. Regulates neutrophil polarization by regulating AKT1 phosphorylation through a mechanism that is independent of PIK3CG activity (By similarity) | 0.714 |
APBA1 | STXBP1 | ENSP00000265381 | ENSP00000362399 | amyloid beta (A4) precursor protein-binding, family A, member 1 | syntaxin binding protein 1; May participate in the regulation of synaptic vesicle docking and fusion, possibly through interaction with GTP-binding proteins. Essential for neurotransmission and binds syntaxin, a component of the synaptic vesicle fusion machinery probably in a 1-1 ratio. Can interact with syntaxins 1, 2, and 3 but not syntaxin 4. May play a role in determining the specificity of intracellular fusion reactions | 0.862 |
APBB2 | APBA1 | ENSP00000427211 | ENSP00000265381 | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.689 |
APBB2 | APLP2 | ENSP00000427211 | ENSP00000263574 | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | amyloid beta (A4) precursor-like protein 2; May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5’-GTCACATG-3’(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts (By similarity) | 0.893 |
APBB2 | APP | ENSP00000427211 | ENSP00000284981 | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | amyloid beta (A4) precursor protein | 0.941 |
APBB2 | KIF17 | ENSP00000427211 | ENSP00000247986 | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | kinesin family member 17; Transports vesicles containing N-methyl-D-aspartate (NMDA) receptor 2B along microtubules (By similarity) | 0.407 |
APBB2 | STXBP1 | ENSP00000427211 | ENSP00000362399 | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | syntaxin binding protein 1; May participate in the regulation of synaptic vesicle docking and fusion, possibly through interaction with GTP-binding proteins. Essential for neurotransmission and binds syntaxin, a component of the synaptic vesicle fusion machinery probably in a 1-1 ratio. Can interact with syntaxins 1, 2, and 3 but not syntaxin 4. May play a role in determining the specificity of intracellular fusion reactions | 0.493 |
APLP2 | APBA1 | ENSP00000263574 | ENSP00000265381 | amyloid beta (A4) precursor-like protein 2; May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5’-GTCACATG-3’(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts (By similarity) | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.875 |
APLP2 | APBB2 | ENSP00000263574 | ENSP00000427211 | amyloid beta (A4) precursor-like protein 2; May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5’-GTCACATG-3’(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts (By similarity) | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | 0.893 |
APLP2 | APP | ENSP00000263574 | ENSP00000284981 | amyloid beta (A4) precursor-like protein 2; May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5’-GTCACATG-3’(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts (By similarity) | amyloid beta (A4) precursor protein | 0.595 |
APP | APBA1 | ENSP00000284981 | ENSP00000265381 | amyloid beta (A4) precursor protein | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.933 |
APP | APBB2 | ENSP00000284981 | ENSP00000427211 | amyloid beta (A4) precursor protein | amyloid beta (A4) precursor protein-binding, family B, member 2; May modulate the internalization of beta-amyloid precursor protein | 0.941 |